Observant investors may know that the U.S. stock market has been enduring a period of underperformance — a fairly unusual ...

Last year, the Food and Drug Administration (FDA) granted approval for CRISPR's gene therapy for sickle cell disease for ...

Pantheon Economics cited a "red flag" in September's jobs market data, and expects that the Fed to deliver more 50 basis ...

September’s jobs report, due out Friday morning, is expected to show that the US labor market has slowed somewhat but remains ...

Friday’s report capped a week of mostly encouraging data on the job market, including an update indicating layoffs remain ...

The Rays dropped to fourth place in the AL East, finishing the season at 80-82. After missing the postseason for ...

"On the face of this the Fed should be hiking rates with these sorts of figures, not cutting rates," Economist James ...

September's 245,000 new jobs topped consensus forecasts by about 100,000. This means the Fed can probably slow the pace of ...

If you're looking for high-yield stocks as October gets underway, look no further than Enbridge, Black Hills, and ...

Last month’s hiring gain was up sharply from the 159,000 jobs that were added in August, and the unemployment dropped from ...

A blockbuster jobs report on Friday paved the way toward a soft landing, in which inflation returns to normal levels while ...

The drug, legal in much of the country, is widely seen as nonaddictive and safe. For some users, these assumptions are ...